As part of The Wistar Institute's Melanoma Research Center, the Villanueva lab pursues new ways to overcome the challenge of melanoma drug resistance. In this paper, the group took aim at melanomas ...

Reported recurrence rates of lentigo maligna treated with Mohs micrographic surgery have ranged from 0.5 to 30.0% in the ...

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant ...

Teddi Mellencamp reveals graphic picture of her surgery scar in honor of World Cancer Day - The Real Housewives of Beverly ...

However, a series of tests said it was nothing to worry about. But the line got darker — and in three months, she was told ...

Melanoma is deadlier for Black individuals due to late diagnoses and hidden symptoms. Understanding the risks can save lives.

The lab of The Wistar Institute's Jessie Villanueva, Ph.D., has identified a new strategy for attacking treatment-resistant melanoma: inhibiting the gene S6K2. .

Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Despite advances in treatments and improvements in survival overall, many oncologists remain hesitant to tell patients ...

Melanoma is a fast-progressing skin cancer characterized by a high mortality rate after metastasis. Local chemotherapy could ...

A new study has linked higher levels of air pollution to a reduced risk of developing melanoma, but an oncologist warns that ...